OneMedNet (NASDAQ:ONMD) CEO Aaron Green Sells 1,667 Shares of Company Stock

OneMedNet Corporation (NASDAQ:ONMD) CEO Aaron Green sold 1,667 shares of the company’s stock in a transaction that occurred on Thursday, September 24th. The shares were sold at an average price of $6.48, for a total value of $10,802.16. Following the completion of the transaction, the chief executive officer directly owned 247,971 shares in the company, valued at $1,606,852.08. The trade was a 0.67% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Aaron Green also recently made the following trade(s):

• On Tuesday, September 22nd, Aaron Green sold 5,000 shares of OneMedNet stock. The shares were sold at an average price of $7.39, for a total value of $36,950.00.

OneMedNet Price Performance

NASDAQ ONMD traded down $0.52 on Friday, reaching $4.30. The stock had a trading volume of 24,653 shares, compared to its average volume of 69,105. The firm has a fifty day moving average of $6.24 and a two-hundred day moving average of $7.32. OneMedNet Corporation has a 1-year low of $4.30 and a 1-year high of $42.20. The company has a market cap of $25.50 million, a P/E ratio of -2.69 and a beta of 1.14.

Analyst Ratings Changes

Separately, Weiss Ratings upgraded shares of OneMedNet from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Monday, August 24th. One equities research analyst has rated the stock with a Sell rating. According to data from MarketBeat, the company has an average rating of “Sell”.

OneMedNet Company Profile

OneMedNet Corporation is a healthcare technology company that develops infrastructure for accessing, managing and analyzing medical data. Its platform is designed to help healthcare providers, researchers, life sciences companies and other authorized users work with clinical and medical-imaging information while keeping the underlying data within the organization that controls it.

The company’s technology uses a federated data model, allowing participating institutions to collaborate on data analysis without routinely transferring sensitive patient information to a centralized repository.